Skip to main content
. 2017 Dec 18;97(3):497–507. doi: 10.1007/s00277-017-3204-6

Fig. 2.

Fig. 2

Clinical outcomes of patients in CR group and advanced group with allo-HSCT. a Cumulative incidence (CI) of relapse, b non-relapse mortality (NRM), c disease-free survival (DFS), d overall survival (OS), and e immunosuppressive agent-free DFS (IDFS)